1 March 2021Insurance

Aegon confirms 'no material impact' from £60m Stonebridge sale

Dutch insurance group Aegon has completed the divestment of Stonebridge, a UK-based provider of accident insurance products, to London-based Global Premium Holdings group, part of Embignell group.

Aegon also confirmed that the transaction will not have a material impact on its capital position and results.

Stonebridge has been closed for new business since 2014. It is a direct to consumer insurer specialising in accidental death and hospitalisation products that provides policies to around 200,000 customers across the UK, Germany, France, Spain, Italy, the Nordics and Ireland.

Aegon sold Stonebridge for a consideration of approximately £60 million, consisting of the purchase price and dividends related to the transaction, excluding a contingent consideration of up to £10 million.

The divestment, first announced in October 2020, is aimed at simplifying Aegon's business profile. It is in line with the insurer's strategy to actively manage its portfolio of businesses, allocating capital to those businesses with a greater potential for an attractive return on capital, and where Aegon sees itself as well positioned for growth.

Did you get value from this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Insurance
11 November 2021   The insurer says it may approach reinsurers to take on some of the risk.
Insurance
30 November 2020   The Dutch insurer seeks to simplify footprint and boost its balance sheet by 'deleveraging'.
Insurance
9 October 2020   The divestment will not impact the Dutch insurer's core business in the UK.